Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
Journal of Neuroinflammation|April 19, 2015
Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotypeAnne-Katrin Pröbstel, Gabrielle Rudolf, Klaus Dornmair, et al.
Plos One|January 26, 2018
Quantitative and qualitative normative dataset for intraepidermal nerve fibers using skin biopsyNicolas Collongues, Brigitte Samama, Catherine Schmidt-Mutter, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 10, 2020
Long-term effect of natalizumab in patients with RRMS: TYSTEN cohortKévin Bigaut, Thibaut Fabacher, Laurent Kremer, et al.
Journal of Neurology|April 25, 2012
Anti-JCV antibody prevalence in a French cohort of MS patients under natalizumab therapyOlivier Outteryck, Jean-Claude Ongagna, Alain Duhamel, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|November 8, 2024
Assessment of the concomitant action of XBD173 and interferon β in a mouse model of multiple sclerosis using infrared marker bandsKrongkarn Sirinukunwattana, Christian Klein, Paul F A Clarke, et al.
Neurology|May 10, 2013
Aquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entityRomain Marignier, Raphaël Bernard-Valnet, Pascale Giraudon, et al.
Multiple Sclerosis and Related Disorders|December 29, 2018
Multiple sclerosis with atypical MRI presentation: Results of a nationwide multicenter study in 57 consecutive casesPekes Codjia, Xavier Ayrignac, Clarisse Carra-Dalliere, et al.
Multiple Sclerosis and Related Disorders|August 26, 2023
Early use of high efficacy therapies in pediatric forms of relapsing-remitting multiple sclerosis: A real-life observational studyAugustin Moreau, Ioanna Kolitsi, Laurent Kremer, et al.
Neurology|February 25, 2021
Pregnancy in Patients With AQP4-Ab, MOG-Ab, or Double-Negative Neuromyelitis Optica DisorderNicolas Collongues, Cecilia Alves Do Rego, Bertrand Bourre, et al.
Multiple Sclerosis and Related Disorders|December 19, 2020
First line treatment failure: Predictive factors in a cohort of 863 Relapsing Remitting MS patientsXavier Ayrignac, Kevin Bigaut, Jean Pelletier, et al.
Pageof 10